Publication Frequency
Quarterly since 2025
Journal Articles
Search
Search scope
Journal Center
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Volume Arrangement
2025
Featured Articles
Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.
Overexpression of miR-150-5p alleviates lipopolysaccharide-induced A549 cell injury in type II alveolar epithelial cells by inhibiting the FSTL1 signaling pathway
Article ID: 4450
Vol 35, Issue 4, 2021
DOI: https://doi.org/10.54517/jbrha4450
Vol 35, Issue 4, 2021
Received: 8 September 2021; Accepted: 8 September 2021; Available online: 8 September 2021; Issue release: 8 September 2021
Keywords
A549 cells inflammatory response;miR-150-5p;FSTL1;ERK1/2
References
Supporting Agencies
Copyright (c) 2021 C-F. Shi, Z-H. Wang, J-C. Li, M-W. Liu
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Editor-in-Chief
Medical Genetics, University of Torino Medical School, Italy
Co-Editor-in-Chief
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy
Indexing & Archiving
News & Announcements
2025-02-01
In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.
2025-01-21
Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.